Quarterly report pursuant to Section 13 or 15(d)

Capital Lease Obligation

v3.19.1
Capital Lease Obligation
9 Months Ended
Mar. 31, 2019
Leases, Capital [Abstract]  
Leases of Lessee Disclosure [Text Block]
8.
Capital Lease Obligation
 
As discussed above, iBio CDMO is leasing its facility in Bryan, Texas as well as certain equipment from the Second Eastern Affiliate under a 34-year sublease (the “sublease”). iBio CDMO began operations at the facility on December 22, 2015 pursuant to agreements between iBio CDMO and the Second Eastern Affiliate granting iBio CDMO temporary rights to access the facility. These temporary agreements were superseded by the Sublease Agreement, dated January 13, 2016, between iBio CDMO and the Second Eastern Affiliate. The 34-year term of the sublease may be extended by iBio CDMO for a ten-year period, so long as iBio CDMO is not in default under the sublease. Under the sublease, iBio CDMO is required to pay base rent at an annual rate of $2,100,000, paid in equal quarterly installments on the first day of each February, May, August and November. The base rent is subject to increase annually in accordance with increases in the Consumer Price Index (“CPI”). The base rent under the Second Eastern Affiliate’s ground lease for the property is subject to adjustment, based on an appraisal of the property, in 2030 and upon any extension of the ground lease. The base rent under the sublease will be increased by any increase in the base rent under the ground lease as a result of such adjustments. iBio CDMO is also responsible for all costs and expenses in connection with the ownership, management, operation, replacement, maintenance and repair of the property under the sublease.
 
In addition to the base rent, iBio CDMO is required to pay, for each calendar year during the term, a portion of the total gross sales for products manufactured or processed at the facility, equal to 7% of the first $5,000,000 of gross sales, 6% of gross sales between $5,000,001 and $25,000,000, 5% of gross sales between $25,000,001 and $50,000,000, 4% of gross sales between $50,000,001 and $100,000,000, and 3% of gross sales between $100,000,001 and $500,000,000. However, if for any calendar year period from January 1, 2018 through December 31, 2019, iBio CDMO’s applicable gross sales are less than $5,000,000, or for any calendar year period from and after January 1, 2020, its applicable gross sales are less than $10,000,000, then iBio CDMO is required to pay the amount that would have been payable if it had achieved such minimum gross sales and shall pay no less than the applicable percentage for the minimum gross sales for each subsequent calendar year. Percentage rent amounted to $87,500 for both the three months ended March 31, 2019 and 2018, and $262,500 and $112,000 for the nine months ended March 31, 2019 and 2018, respectively.
 
Interest expense incurred under the capital lease obligation amounted to approximately $474,000 and $478,000 for the three months ended March 31, 2019 and 2018, respectively, and $1,426,000 and $1,437,000 for the nine months ended March 31, 2019 and 2018, respectively. 
 
Future minimum payments under the capitalized lease obligation are due as follows:
 
Fiscal period ending on March 31:
 
Principal
 
 
Interest
 
 
Total
 
2019
 
$
208,924
 
 
$
1,891,076
 
 
$
2,100,000
 
2020
 
 
225,277
 
 
 
1,874,723
 
 
 
2,100,000
 
2021
 
 
242,911
 
 
 
1,857,089
 
 
 
2,100,000
 
2022
 
 
261,924
 
 
 
1,838,076
 
 
 
2,100,000
 
2023
 
 
282,426
 
 
 
1,817,574
 
 
 
2,100,000
 
Thereafter
 
 
23,713,438
 
 
 
30,886,562
 
 
 
54,600,000
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Total minimum lease payments
 
 
24,934,900
 
 
$
40,165,100
 
 
$
65,100,000
 
Less: current portion
 
 
(208,924
)
 
 
 
 
 
 
 
 
Long-term portion of minimum lease obligations
 
$
24,725,976